Immunogenicity, reactogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ Rotarix Porcine circovirus (PCV)-free liquid compared to Rotarix liquid given in 2-doses in healthy Chinese infants starting at age 6-16 weeks

Trial Identifier: 212692
Sponsor: GlaxoSmithKline
Start Date: September 2023
Primary Completion Date: May 2024
Study Completion Date: October 2024
Condition: Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Baoshan, China, 678099
China Baoshan, China, 678199
China Baoshan, China, 678399
China Dali, China, 672499
China Honghe, China, 652399
China Mianyang, China, 610041
China Mianyang, China
China Nanbu-Nanchong, China, 637300
China Neijiang, China, 641200
China Tengchong, China, 679100
China Wenshan, China, 650034
China WENSHAN, China, 663300